Wendy Sussman

Vice President of U.S. Healthcare Government & Public Affairs


Profile

Wendy Sussman is the Vice President of U.S. Healthcare Government & Public Affairs at EMD Serono.

Wendy leads a team responsible for all legislative, policy, and advocacy strategy and execution to support all facets of EMD Serono’s U.S. business.

Wendy brings more than 20 years of experience leading government and public affairs teams in the health care arena.

Before joining EMD Serono, Wendy was Vice President of U.S. Public Affairs at Sandoz, a Novartis division.  In this role Wendy managed a team responsible for federal, state, policy and alliance development functions focused on generics and biosimilar medicines.

Prior to that, Wendy was Head of U.S. Government Affairs at Hospira Inc., as well as Vice President of Government Affairs at CVS Caremark Corporation (now CVS Health).

She also held several Government Affairs roles previously at the Federation of American Hospitals, the American Association of Nurse Anesthetists, as well as the American Dental Association. 

Wendy holds her BA in Government & Law and International Affairs from Lafayette College.

Redirect

You have accessed https://www.emdgroup.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Site Exit Disclaimer

You are now leaving the website of EMD Serono, the biopharma business of Merck KGaA, Darmstadt, Germany. This link will either lead to a different website maintained by EMD Serono/its global business, or a different website/resource maintained by 3rd parties.

If you are visiting a 3rd party website, we have no control over the content and are not responsible for and make no representation as to the accuracy or any other aspect of such resource or the privacy practices of such 3rd party. Providing links to a 3rd party website does not constitute EMD Serono’s endorsement of such website or the information or products presented on such website. 

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement